CARMEL, Ind., Dec. 20, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, today announced the expansion of its healthcare workforce business unit to include additional offerings.
The expanded products and services include:
Through accessible learning and development resources, Syra Health's newly added healthcare workforce solutions offer workers the opportunity to develop new skill sets or expand their existing competencies to meet the changing needs of healthcare. For those new to the healthcare workforce, Syra Health also offers apprenticeship programs.
Syra Health's new healthcare workforce solutions technology platform allows employers to post open healthcare positions. Job seekers can log in and look for opportunities to apply for while managing their profile information. Employers can search for the talent they are looking for based on desired characteristics and candidate profiles.
"We have a successful track record in providing healthcare workforce solutions to state and local governments," said Sandeep Allam, Executive Chairman and President, Syra Health. "Extending our offerings to healthcare employers and healthcare talent is a natural progression of our expertise."
Syra Health's workforce engagement solutions include monitoring the pulse of the workplace culture to ensure healthcare employees feel safe, valued, and protected. Syra Health's workforce concierge service streamlines communications with candidates and current employees while helping employers respond to unexpected challenges that arise within the workplace.
"A supported workforce is a productive workforce," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "Our workforce surveys, assessments, and analytics capabilities allow us to pinpoint healthy cultures and those where additional training may be needed."
According to the American Hospital Association's (AHA) 2024 Healthcare Workforce Scan, the healthcare workforce shortage will continue throughout 2024 as workers cite burnout, staff shortages, and retirement as key factors driving their departures. The report also explains the need for a supportive workplace to offset incivility and sustainable talent pipelines to address the unevenly distributed workforce.
About Syra Health:
Syra Health is a healthcare company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Health's products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and government. For more information, please visit www.syrahealth.com.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.94 |
Daily Change: | -0.06 -5.86 |
Daily Volume: | 138,116 |
Market Cap: | US$6.220M |
August 08, 2024 July 30, 2024 May 14, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB